Cost Of Care

Twenty Percent of New Cancer Treatments Do Not Offer a Clinical Benefit

Twenty Percent of New Cancer Treatments Do Not Offer a Clinical Benefit

By

While cancer drugs improved quality of life, the average overall survival increase was only 3.43 months, and many drugs reduced patient safety.

The Cost of Lower Costs: 2 Sides of Pharmaceutical Patient Assistance Programs

The Cost of Lower Costs: 2 Sides of Pharmaceutical Patient Assistance Programs

By

Patient Assistance Programs for cancer-related therapies are offered by most drug companies, as well as numerous nonprofit organizations, and can help reduce the "financial toxicity" of treatment. But information about PAPs can be scarce and application processes are frequently cumbersome, with eligibility criteria varying from program to program.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs